Literature DB >> 27552618

Association of RNA Biosignatures With Bacterial Infections in Febrile Infants Aged 60 Days or Younger.

Prashant Mahajan1, Nathan Kuppermann2, Asuncion Mejias3, Nicolas Suarez3, Damien Chaussabel4, T Charles Casper5, Bennett Smith3, Elizabeth R Alpern6, Jennifer Anders7, Shireen M Atabaki8, Jonathan E Bennett9, Stephen Blumberg10, Bema Bonsu11, Dominic Borgialli12, Anne Brayer13, Lorin Browne14, Daniel M Cohen15, Ellen F Crain9, Andrea T Cruz16, Peter S Dayan17, Rajender Gattu18, Richard Greenberg19, John D Hoyle20, David M Jaffe21, Deborah A Levine22, Kathleen Lillis23, James G Linakis24, Jared Muenzer25, Lise E Nigrovic26, Elizabeth C Powell27, Alexander J Rogers28, Genie Roosevelt29, Richard M Ruddy30, Mary Saunders31, Michael G Tunik32, Leah Tzimenatos33, Melissa Vitale34, J Michael Dean5, Octavio Ramilo3.   

Abstract

IMPORTANCE: Young febrile infants are at substantial risk of serious bacterial infections; however, the current culture-based diagnosis has limitations. Analysis of host expression patterns ("RNA biosignatures") in response to infections may provide an alternative diagnostic approach.
OBJECTIVE: To assess whether RNA biosignatures can distinguish febrile infants aged 60 days or younger with and without serious bacterial infections. DESIGN, SETTING, AND PARTICIPANTS: Prospective observational study involving a convenience sample of febrile infants 60 days or younger evaluated for fever (temperature >38° C) in 22 emergency departments from December 2008 to December 2010 who underwent laboratory evaluations including blood cultures. A random sample of infants with and without bacterial infections was selected for RNA biosignature analysis. Afebrile healthy infants served as controls. Blood samples were collected for cultures and RNA biosignatures. Bioinformatics tools were applied to define RNA biosignatures to classify febrile infants by infection type. EXPOSURE: RNA biosignatures compared with cultures for discriminating febrile infants with and without bacterial infections and infants with bacteremia from those without bacterial infections. MAIN OUTCOMES AND MEASURES: Bacterial infection confirmed by culture. Performance of RNA biosignatures was compared with routine laboratory screening tests and Yale Observation Scale (YOS) scores.
RESULTS: Of 1883 febrile infants (median age, 37 days; 55.7% boys), RNA biosignatures were measured in 279 randomly selected infants (89 with bacterial infections-including 32 with bacteremia and 15 with urinary tract infections-and 190 without bacterial infections), and 19 afebrile healthy infants. Sixty-six classifier genes were identified that distinguished infants with and without bacterial infections in the test set with 87% (95% CI, 73%-95%) sensitivity and 89% (95% CI, 81%-93%) specificity. Ten classifier genes distinguished infants with bacteremia from those without bacterial infections in the test set with 94% (95% CI, 70%-100%) sensitivity and 95% (95% CI, 88%-98%) specificity. The incremental C statistic for the RNA biosignatures over the YOS score was 0.37 (95% CI, 0.30-0.43). CONCLUSIONS AND RELEVANCE: In this preliminary study, RNA biosignatures were defined to distinguish febrile infants aged 60 days or younger with vs without bacterial infections. Further research with larger populations is needed to refine and validate the estimates of test accuracy and to assess the clinical utility of RNA biosignatures in practice.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27552618      PMCID: PMC5122927          DOI: 10.1001/jama.2016.9207

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  33 in total

1.  Genomics and microbiology. Microbial forensics--"cross-examining pathogens".

Authors:  Craig A Cummings; David A Relman
Journal:  Science       Date:  2002-05-09       Impact factor: 47.728

Review 2.  Clinically relevant, cost-effective clinical microbiology. Strategies to decrease unnecessary testing.

Authors:  M L Wilson
Journal:  Am J Clin Pathol       Date:  1997-02       Impact factor: 2.493

3.  Urinary tract infections in young febrile children.

Authors:  A Hoberman; E R Wald
Journal:  Pediatr Infect Dis J       Date:  1997-01       Impact factor: 2.129

Review 4.  Performance of low-risk criteria in the evaluation of young infants with fever: review of the literature.

Authors:  Anna R Huppler; Jens C Eickhoff; Ellen R Wald
Journal:  Pediatrics       Date:  2010-01-18       Impact factor: 7.124

5.  Serious bacterial infections in febrile infants younger than 90 days of age: the importance of ampicillin-resistant pathogens.

Authors:  Carrie L Byington; Kristine K Rittichier; Kathlene E Bassett; Heidi Castillo; Tiffany S Glasgow; Judy Daly; Andrew T Pavia
Journal:  Pediatrics       Date:  2003-05       Impact factor: 7.124

6.  Diagnostic value of procalcitonin in well-appearing young febrile infants.

Authors:  Borja Gomez; Silvia Bressan; Santiago Mintegi; Liviana Da Dalt; Daniel Blazquez; Izaskun Olaciregui; Mercedes de la Torre; Miriam Palacios; Paola Berlese; Aitor Ruano
Journal:  Pediatrics       Date:  2012-10-29       Impact factor: 7.124

7.  A modular analysis framework for blood genomics studies: application to systemic lupus erythematosus.

Authors:  Damien Chaussabel; Charles Quinn; Jing Shen; Pinakeen Patel; Casey Glaser; Nicole Baldwin; Dorothee Stichweh; Derek Blankenship; Lei Li; Indira Munagala; Lynda Bennett; Florence Allantaz; Asuncion Mejias; Monica Ardura; Ellen Kaizer; Laurence Monnet; Windy Allman; Henry Randall; Diane Johnson; Aimee Lanier; Marilynn Punaro; Knut M Wittkowski; Perrin White; Joseph Fay; Goran Klintmalm; Octavio Ramilo; A Karolina Palucka; Jacques Banchereau; Virginia Pascual
Journal:  Immunity       Date:  2008-07-18       Impact factor: 31.745

8.  An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis.

Authors:  Matthew P R Berry; Christine M Graham; Finlay W McNab; Zhaohui Xu; Susannah A A Bloch; Tolu Oni; Katalin A Wilkinson; Romain Banchereau; Jason Skinner; Robert J Wilkinson; Charles Quinn; Derek Blankenship; Ranju Dhawan; John J Cush; Asuncion Mejias; Octavio Ramilo; Onn M Kon; Virginia Pascual; Jacques Banchereau; Damien Chaussabel; Anne O'Garra
Journal:  Nature       Date:  2010-08-19       Impact factor: 49.962

9.  Host immune transcriptional profiles reflect the variability in clinical disease manifestations in patients with Staphylococcus aureus infections.

Authors:  Romain Banchereau; Alejandro Jordan-Villegas; Monica Ardura; Asuncion Mejias; Nicole Baldwin; Hui Xu; Elizabeth Saye; Jose Rossello-Urgell; Phuong Nguyen; Derek Blankenship; Clarence B Creech; Virginia Pascual; Jacques Banchereau; Damien Chaussabel; Octavio Ramilo
Journal:  PLoS One       Date:  2012-04-04       Impact factor: 3.240

10.  Whole blood gene expression profiles to assess pathogenesis and disease severity in infants with respiratory syncytial virus infection.

Authors:  Asuncion Mejias; Blerta Dimo; Nicolas M Suarez; Carla Garcia; M Carmen Suarez-Arrabal; Tuomas Jartti; Derek Blankenship; Alejandro Jordan-Villegas; Monica I Ardura; Zhaohui Xu; Jacques Banchereau; Damien Chaussabel; Octavio Ramilo
Journal:  PLoS Med       Date:  2013-11-12       Impact factor: 11.069

View more
  69 in total

1.  Time to Pathogen Detection for Non-ill Versus Ill-Appearing Infants ≤60 Days Old With Bacteremia and Meningitis.

Authors:  Paul L Aronson; Marie E Wang; Lise E Nigrovic; Samir S Shah; Sanyukta Desai; Christopher M Pruitt; Fran Balamuth; Laura Sartori; Richard D Marble; Sahar N Rooholamini; Rianna C Leazer; Christopher Woll; Adrienne G DePorre; Mark I Neuman
Journal:  Hosp Pediatr       Date:  2018-07

2.  Validation of a Host Response Assay, SeptiCyte LAB, for Discriminating Sepsis from Systemic Inflammatory Response Syndrome in the ICU.

Authors:  Russell R Miller; Bert K Lopansri; John P Burke; Mitchell Levy; Steven Opal; Richard E Rothman; Franco R D'Alessio; Venkataramana K Sidhaye; Neil R Aggarwal; Robert Balk; Jared A Greenberg; Mark Yoder; Gourang Patel; Emily Gilbert; Majid Afshar; Jorge P Parada; Greg S Martin; Annette M Esper; Jordan A Kempker; Mangala Narasimhan; Adey Tsegaye; Stella Hahn; Paul Mayo; Tom van der Poll; Marcus J Schultz; Brendon P Scicluna; Peter Klein Klouwenberg; Antony Rapisarda; Therese A Seldon; Leo C McHugh; Thomas D Yager; Silvia Cermelli; Dayle Sampson; Victoria Rothwell; Richard Newman; Shruti Bhide; Brian A Fox; James T Kirk; Krupa Navalkar; Roy F Davis; Roslyn A Brandon; Richard B Brandon
Journal:  Am J Respir Crit Care Med       Date:  2018-10-01       Impact factor: 21.405

Review 3.  Gene Expression Profiles in Children With Suspected Sepsis.

Authors:  Fran Balamuth; Elizabeth R Alpern; Mengyuan Kan; Maya Shumyatcher; Katie Hayes; Ebbing Lautenbach; Blanca E Himes
Journal:  Ann Emerg Med       Date:  2020-01-23       Impact factor: 5.721

4.  Correction of Cerebrospinal Fluid Protein in Infants With Traumatic Lumbar Punctures.

Authors:  Todd W Lyons; Andrea T Cruz; Stephen B Freedman; Joseph L Arms; Paul L Aronson; Alesia H Fleming; Dina M Kulik; Prashant Mahajan; Rakesh D Mistry; Christopher M Pruitt; Amy D Thompson; Lise E Nigrovic
Journal:  Pediatr Infect Dis J       Date:  2017-10       Impact factor: 2.129

5.  Impact of Enteroviral Polymerase Chain Reaction Testing on Length of Stay for Infants 60 Days Old or Younger.

Authors:  Paul L Aronson; Todd W Lyons; Andrea T Cruz; Stephen B Freedman; Pamela J Okada; Alesia H Fleming; Joseph L Arms; Amy D Thompson; Suzanne M Schmidt; Jeffrey Louie; Michael J Alfonzo; Michael C Monuteaux; Lise E Nigrovic
Journal:  J Pediatr       Date:  2017-07-10       Impact factor: 4.406

6.  Interpretation of Cerebrospinal Fluid White Blood Cell Counts in Young Infants With a Traumatic Lumbar Puncture.

Authors:  Todd W Lyons; Andrea T Cruz; Stephen B Freedman; Mark I Neuman; Fran Balamuth; Rakesh D Mistry; Prashant Mahajan; Paul L Aronson; Joanna E Thomson; Christopher M Pruitt; Samir S Shah; Lise E Nigrovic
Journal:  Ann Emerg Med       Date:  2016-12-29       Impact factor: 5.721

7.  Association of Herpes Simplex Virus Testing with Hospital Length of Stay for Infants ≤60 Days of Age Undergoing Evaluation for Meningitis.

Authors:  Paul L Aronson; Andrea T Cruz; Stephen B Freedman; Fran Balamuth; Kendra L Grether-Jones; Todd W Lyons; Alesia H Fleming; Jeffrey Louie; Rakesh D Mistry; Aris C Garro; Samir S Shah; Lise E Nigrovic
Journal:  J Hosp Med       Date:  2019-05-12       Impact factor: 2.960

8.  The Yale Observation Scale Score and the Risk of Serious Bacterial Infections in Febrile Infants.

Authors:  Lise E Nigrovic; Prashant V Mahajan; Stephen M Blumberg; Lorin R Browne; James G Linakis; Richard M Ruddy; Jonathan E Bennett; Alexander J Rogers; Leah Tzimenatos; Elizabeth C Powell; Elizabeth R Alpern; T Charles Casper; Octavio Ramilo; Nathan Kuppermann
Journal:  Pediatrics       Date:  2017-06-06       Impact factor: 7.124

Review 9.  Early Diagnosis of Sepsis: Is an Integrated Omics Approach the Way Forward?

Authors:  Raymond J Langley; Hector R Wong
Journal:  Mol Diagn Ther       Date:  2017-10       Impact factor: 4.074

10.  Time to Positive Blood and Cerebrospinal Fluid Cultures in Febrile Infants ≤60 Days of Age.

Authors:  Elizabeth R Alpern; Nathan Kuppermann; Stephen Blumberg; Genie Roosevelt; Andrea T Cruz; Lise E Nigrovic; Lorin R Browne; John M VanBuren; Octavio Ramilo; Prashant Mahajan
Journal:  Hosp Pediatr       Date:  2020-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.